Page 49 - Clinical Development News Today

The US Food and Drink Administration (FDA) has approved Calliditas Therapeutics' Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with IgAN.

Bristol Myers Squibb has announced it has acquired Karuna Therapeutics, Inc., for a total equity value of $14 billion or $12.7 billion net of estimated cash.

A Los Angeles clinic is holding a free webinar covering the facts and myths about ketamine following the death of late actor, Matthew Perry.

Over the last year, we’ve seen how rapid technology adoption, namely AI, can impact clinical trials.

Tonix recently reported results from second positive Phase 3 trial of Tonmya™ for the management of fibromyalgia In the U.S., New Drug Application (NDA) submission to the FDA planned for the second half of 2024 In Japan, China and most countries in Europe cyclobenzaprine is a New Chemical Entity CHATHAM, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of de...

From Hertford, St Albans an beyond, over 20 Hertfordshire residents have been included in this years New Year Honours list.

From Hertford, St Albans an beyond, over 20 Hertfordshire residents have been included in this years New Year Honours list.

From Hertford, St Albans an beyond, over 20 Hertfordshire residents have been included in this years New Year Honours list.

From Hertford, St Albans an beyond, over 20 Hertfordshire residents have been included in this years New Year Honours list.

The prescribing information for Yescarta® (axicabtagene ciloleucel) has been updated to include OS data in adults with relapsed or refractory LBCL.